Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H23N5O2 |
InChIKeyDBWCQHQSBPWMNN-UHFFFAOYSA-N |
CAS Registry1227408-89-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Phase 1 | JP | 31 Mar 2019 | |
Irritable Bowel Syndrome | Phase 1 | GB | 03 Feb 2016 |